Clinical and Urodynamic Evaluation of Surgical Repair of Pelvic Organ Prolapse Associated With Lower Urinary Tract Symptoms

Ain Shams University0 sites83 target enrollmentDecember 1, 2014

ConditionsPelvic Organ Prolapse

Overview

Phase: Phase 2
Intervention: Not specified
Conditions: Pelvic Organ Prolapse
Sponsor: Ain Shams University
Enrollment: 83
Primary Endpoint: Urodynamic study evaluation for the participants
Status: Completed
Last Updated: 5 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

To assess the urinary symptoms and urodynamic findings concomitant with Pelvic organ prolapse before and after surgical treatment and to define the role of urodynamic study in treatment decision making.

Detailed Description

Pelvic organ prolapse (POP) is a prevalent problem that affects women's quality of life women with POP may present with a variety of lower urinary tract symptoms (LUTS). For POP patients with concomitant urinary symptoms, urodynamic (UDN) testing is proposed for proper evaluation of cases and identification of the pathophysiologic events in each case individually. In this prospective study, the investigators aim to describe the urinary symptoms and urodynamic findings concomitant with POP before and after surgical treatment of POP. We also aimed at defining the role of UDN in decision-making regarding the treatment of POP when associated with LUTS.

Registry

clinicaltrials.gov

Start Date

December 1, 2014

End Date

December 1, 2018

Last Updated

5 years ago

Study Type

Interventional

Study Design

Single Group

Sex

Female

Investigators

Sponsor

Ain Shams University

Responsible Party

Principal Investigator

Ahmed Maher Gamil Ahmed Higazy

Assistant lecturer

Ain Shams University

Eligibility Criteria

Inclusion Criteria

•women with anterior pelvic organ prolapse (POP) associated with Lower urinary tract symptoms

Exclusion Criteria

•Patients with POP less than POP-Q grade II, POP not in need for surgical repair, neurological diseases that could possibly affect voiding functions, pelvic infections, congenital bladder disorders, history of urinary fistula, history of malignancy, and patients on current medical treatment for voiding dysfunction.